Search research articles
Contact Us
Filters
Showing results (321-330 of 770) with videos related to
Page
of 77
Sort By:
Clinical Diabetes : a Publication of the American Diabetes Association
|
July 17, 2023
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100)
Steven Edelman, Jennifer Goldman, Daniel C Malone, et al.
International Journal of MS Care
|
March 6, 2015
Lower urinary tract symptom prevalence and management among patients with multiple sclerosis
Kristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 6, 1997
A national estimate of the economic costs of asthma
D H Smith, D C Malone, K A Lawson, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
July 31, 2010
Efficiency and economic benefits of a payer-based electronic health record in an emergency department
Gregory W Daniel, Edward Ewen, Vincent J Willey, et al.
Journal of Medical Economics
|
June 7, 2016
The economic burden of spinal muscular atrophy
Edward P Armstrong, Daniel C Malone, Wei-Shi Yeh, et al.
BMC Medical Informatics and Decision Making
|
March 19, 2013
Evaluation of a drug-drug interaction: fax alert intervention program
Edward P Armstrong, Sharon M Wang, Lisa E Hines, et al.
Journal of Managed Care Pharmacy : JMCP
|
June 24, 2006
Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies
Jacob Abarca, Lisa R Colon, Victoria S Wang, et al.
Drug Safety
|
October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"
Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
Research in Social & Administrative Pharmacy : RSAP
|
March 15, 2011
A drug-drug interaction knowledge assessment instrument for health professional students: a Rasch analysis of validity evidence
Terri L Warholak, J Michael Menke, Lisa E Hines, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 25, 2015
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
Haesuk Park, Karen L Rascati, Kenneth A Lawson, et al.
Page
of 77
Search research articles
Search
Showing results (321-330 of 770) with videos related to
Sort By:
Page
of 77
Clinical Diabetes : a Publication of the American Diabetes Association
|
July 17, 2023
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100)
Steven Edelman, Jennifer Goldman, Daniel C Malone, et al.
International Journal of MS Care
|
March 6, 2015
Lower urinary tract symptom prevalence and management among patients with multiple sclerosis
Kristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 6, 1997
A national estimate of the economic costs of asthma
D H Smith, D C Malone, K A Lawson, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
July 31, 2010
Efficiency and economic benefits of a payer-based electronic health record in an emergency department
Gregory W Daniel, Edward Ewen, Vincent J Willey, et al.
Journal of Medical Economics
|
June 7, 2016
The economic burden of spinal muscular atrophy
Edward P Armstrong, Daniel C Malone, Wei-Shi Yeh, et al.
BMC Medical Informatics and Decision Making
|
March 19, 2013
Evaluation of a drug-drug interaction: fax alert intervention program
Edward P Armstrong, Sharon M Wang, Lisa E Hines, et al.
Journal of Managed Care Pharmacy : JMCP
|
June 24, 2006
Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies
Jacob Abarca, Lisa R Colon, Victoria S Wang, et al.
Drug Safety
|
October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"
Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
Research in Social & Administrative Pharmacy : RSAP
|
March 15, 2011
A drug-drug interaction knowledge assessment instrument for health professional students: a Rasch analysis of validity evidence
Terri L Warholak, J Michael Menke, Lisa E Hines, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 25, 2015
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
Haesuk Park, Karen L Rascati, Kenneth A Lawson, et al.
Page
of 77